Proceedings of the National Academy of Sciences · 2011 · 125 citations · 25 references
Life SciencesMolecular BiologyPharmacologyAntimicrobial ResistanceDrug DiscoveryEnzymologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance GeneticsAntibiotic Resistance MechanismsMechanisms Of Antimicrobial ResistanceMultidrug ResistanceAminoglycoside AntibioticsAminoglycoside Resistance MechanismsBacterial Multidrug ResistanceExtensively Drug-resistant Tuberculosis TreatmentMolecular Drug ResistanceMycobacterial DiseaseMycobacterium Tuberculosis InfectionTuberculosis Drug Resistance
The emergence of multidrug-resistant and extensively drug-resistant (XDR) tuberculosis (TB) is a serious global threat. Aminoglycoside antibiotics are used as a last resort to treat XDR-TB. Resistance to the aminoglycoside kanamycin is a hallmark of XDR-TB. Here, we reveal the function and structure of the mycobacterial protein Eis responsible for resistance to kanamycin in a significant fraction of kanamycin-resistant Mycobacterium tuberculosis clinical isolates. We demonstrate that Eis has an unprecedented ability to acetylate multiple amines of many aminoglycosides. Structural and mutagenesis studies of Eis indicate that its acetylation mechanism is enabled by a complex tripartite fold that includes two general control non-derepressible 5 (GCN5)-related N-acetyltransferase regions. An intricate negatively charged substrate-binding pocket of Eis is a potential target of new antitubercular drugs expected to overcome aminoglycoside resistance.
25
Patricia Campbell, Glenn P. Morlock, R. David Sikes et al. · Antimicrobial Agents and Chemotherapy · 2011 · 378 citations
M. Analise Zaunbrecher, R. David Sikes, Beverly Metchock et al. · Proceedings of the National Academy of Sciences · 2009 · 333 citations · Full text